Health Care

Groups say Medicare discounts threatened in opioids bill

Consumer and health care groups say they're trying to block the pharmaceutical industry from commandeering opioid legislation and using it to roll back drugmaker discounts to Medicare beneficiaries with high prescription costs.

Biopharmaceutical company fined for misleading investors

A Colorado-based biopharmaceutical company has been penalized more than $20 million for misleading investors about the efficacy of a lung cancer drug under development before raising $300 million in a public stock offering.

Canadian marijuana imports OK'd by US for California study

In a rare move, the U.S. government has approved the importation of marijuana extracts from Canada for a clinical trial, highlighting a new avenue for American researchers who have long had trouble obtaining the drug for medical studies.

Duck boat operators criticize attorney general's lawsuit

The operators of a Missouri duck boat that sank in July, killing 17 people, say in a court filing that a lawsuit from Missouri's attorney general is "irresponsible" and "littered with factual inaccuracies and innuendo."